HFpEF: is splitting into distinct phenotypes by comorbidities the pathway forward?

J Am Coll Cardiol. 2014 Aug 12;64(6):550-2. doi: 10.1016/j.jacc.2014.06.010.

Authors

Mathew S Maurer¹, Donna Mancini²

Affiliations

¹ Department of Medicine, Division of Cardiology, Columbia University Medical Center, New York, New York.
² Department of Medicine, Division of Cardiology, Columbia University Medical Center, New York, New York. Electronic address: [email protected].

PMID: 25104522
DOI: 10.1016/j.jacc.2014.06.010

No abstract available

Keywords: diabetes; heart failure with preserved ejection fraction.

Publication types

Editorial
Comment

MeSH terms

Diabetes Mellitus / diagnosis*
Female
Heart Failure / epidemiology*
Humans
Male
Phenotype*
Phosphodiesterase 5 Inhibitors / therapeutic use*
Stroke Volume / physiology*

Substances

Phosphodiesterase 5 Inhibitors